PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAF9F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $18,760
Award facts
- Contract value 100% obligated
- $18,760.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $18.76K, was awarded on January 19, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., under a firm fixed-price contract with no set-aside designation. The order is performable in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026, and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement. This delivery order represents a task order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $1 billion vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs.
AmerisourceBergen has demonstrated substantial capability in federal pharmaceutical distribution through competitive awards across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's parent organization, Cencora, Inc., holds the underlying $1 billion DLA IDC and maintains additional federal contracts with the Department of Veterans Affairs and Department of Justice Federal Bureau of Investigation. The DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts, with anticipated multiple awards across regions, positioning AmerisourceBergen to continue serving critical federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2D826FAF9F?
SPE2D826FAF9F was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FAF9F worth?
The government has obligated $18,760 on SPE2D826FAF9F.
Is contract SPE2D826FAF9F an order under another contract?
Yes. SPE2D826FAF9F is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAF9F competed?
The extent of competition for SPE2D826FAF9F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award